Apoptotic genes expression in head and neck squamous cell carcinoma (HNSCC) patients (2010)
- Autores:
- Autores USP: MICHALUART JUNIOR, PEDRO - FM ; CASTRO, FABÍOLA ATTIÉ DE - FCFRP ; MENDES, JOAO GUSTAVO PESSINI AMARANTE - ICB
- Unidades: FM; FCFRP; ICB
- Assuntos: MELANOMA; METÁSTASE NEOPLÁSICA; CÉLULAS MORTAS
- Idioma: Inglês
- Imprenta:
- Fonte:
- Nome do evento: Signaling cell death, cancer and immune system
-
ABNT
BARROS, Bruna Figueiredo et al. Apoptotic genes expression in head and neck squamous cell carcinoma (HNSCC) patients. Einstein. São Paulo: Faculdade de Medicina, Universidade de São Paulo. . Acesso em: 02 out. 2024. , 2010 -
APA
Barros, B. F., Ferreira, A., Diniz, D. C., Zenteno, M. E., Michaluart Junior, P., Tajara, E. H., et al. (2010). Apoptotic genes expression in head and neck squamous cell carcinoma (HNSCC) patients. Einstein. São Paulo: Faculdade de Medicina, Universidade de São Paulo. -
NLM
Barros BF, Ferreira A, Diniz DC, Zenteno ME, Michaluart Junior P, Tajara EH, Castro FA de, Jacysyn J, Amarante-Mendes JGP. Apoptotic genes expression in head and neck squamous cell carcinoma (HNSCC) patients. Einstein. 2010 ; 8 S29.[citado 2024 out. 02 ] -
Vancouver
Barros BF, Ferreira A, Diniz DC, Zenteno ME, Michaluart Junior P, Tajara EH, Castro FA de, Jacysyn J, Amarante-Mendes JGP. Apoptotic genes expression in head and neck squamous cell carcinoma (HNSCC) patients. Einstein. 2010 ; 8 S29.[citado 2024 out. 02 ] - Development and characterization of murine models of T lymphoma to investigate the impact of oncogene expression
- Conversion of CD95 (Fas) type II into type I signaling by sub-lethal doses of cycloheximide
- T lymphoma murine models to study the impact of ectopic expression of anti-apoptotic oncogenes
- Cosmomycin D, an anthracycline more potent than Doxorubicin for induction of tumor cell death, synergize with imatinib mesilate to induce apoptosis in Bcr-Abl-positive cells
- Study of pro and anti-apoptotic genes to understand the resistance of apoptosis mediated by Bcr-Abl
- BH3 mimetics and TKI combined therapy for Chronic Myeloid Leukemia
- Contribuição para o desenvolvimento da imunoterapia para o tratamento do carcinoma epidermóide de cabeça e pescoço
- Inibição da cicloxigenase-2 por antioxidantes fenólicos: nova estratégia para a quimioprevenção do câncer de cabeça e pescoço
- Microrna-7 and cell-signaling deregulation in head and neck squamous cell carcinoma
- Indoleamine 2,3-dioxygenase expression in chronic myelogenous leukemia patients: association with disease progression
Como citar
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
